Inflammasome pathway component expressions in myocardial samples of advanced heart failure patients treated with novel heart failure pharmacotherapies
{{output}}
Background: The inflammasome pathway has been implicated in the progression of heart failure (HF). Preclinical studies suggest that angiotensin receptor-neprilysin inhibitor (ARNi) and sodium-glucose cotransporter-2 inhibitor (SG... ...
